Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
The MSL Career Ladder…What options are available and how to position yourself for advancement with Davida White
Summary
In this episode, Davida White shares her insights on the evolving landscape of Medical Science Liaison roles and medical affairs. She discusses her career journey and emphasizes the importance of growth opportunities, particularly through medical support roles. Davida highlights the significance of taking initiative, prioritizing experience over job titles, and setting career goals with leadership. She also delves into the role of mentorship and networking in career advancement. The conversation touches on adapting to post-COVID-19 changes and the strategic value of lateral career moves. The episode concludes with Davida's thoughts on summertime plans.
My guest today is Davida White, US Oncology Field Medical Alignment Director at Merck and we discuss the MSL Career Ladder and what career options are available to MSLs as well as how to position yourself for promotion.
In this episode:
- Davida’s background and her work now
- Her journey and transition to the industry
- What options are available past the title or the role of an MSL
- Pursuing some of these career options for MSLs
- Management development programs
- Her take on mentors and mentorship type programs
- Skills to be developed for MSLs to advance their careers
- Advice for people to help them get noticed and what steps should be taken
Medical Science Liaison, career advancement, mentorship and networking, strategic career moves, MSL career ladder
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO